Within 24 hours of injecting the first dose of a weight-loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said.
Jun 3, 2026
Soon after starting his freshman year at Washington State University in 2022, Luke Tyler spotted an Instagram ad that offered hope for his anxiety and undiagnosed depression.
Mar 26, 2026
Semaglutide, a drug marketed under the brand names Ozempic, Rybelsus and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used in the treatment of type 2 diabetes and obesity.
Jan 13, 2025
Tirzepatide, known by the brand names Mounjaro and Zepbound, is an injectable drug approved by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D) and obesity.
Feb 12, 2025